Evaluation of Intubation Conditions Following BX1000 or Rocuronium in Subjects Undergoing Surgery

• Status: Recruiting
• Trial end date: 2023-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Assessment of Intubation conditions following administration of neuromuscular blocking agents; BX1000 (investigational) or rocuronium (active control).

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Baudax Bio
• Treatments: Bromides; Rocuronium

Criteria

Inclusion Criteria:

• Providing informed consent

• Undergoing elective surgery utilizing IV general anesthesia

• Normal airway assessment

Exclusion Criteria:

• Unstable disease or emergency surgical conditions

• Known hypersensitivity to rocuronium, other NMB or study medications

• History of anaphylaxis

• History of neuromuscular junction disease

• Personal or family history of malignant hyperthermia or pseudocholinesterase deficiency

• Diagnosed or suspected sleep apnea

• History of prior anesthetic complications